Select Page

2022 Consensus Conference to Implement Optimal
VTE Prophylaxis in Trauma

Attendees of the 2022 VTE Consensus Conference, held at the American College of Surgeons in May 2022.

The 2022 Consensus Conference to Implement Optimal VTE Prophylaxis in Trauma was held May 4-5, 2022 and convened a multi-disciplinary group of stakeholders with wide ranging areas of expertise and focus in injury care and venous thromboembolism (VTE) in trauma. It was presented by CNTR, hosted by the American College of Surgeons, and co-led by VTE investigators Todd Costantini, MD, and Elliott R. Haut, MD, PhD.

With 40 in-person attendees and more than 80 surgeons, pharmacists, trauma program leaders, nurses and others registered to attend virtually, the conference’s primary objectives were realized: to promote research related to the perceived barriers to delivering timely pharmacologic VTE prophylaxis, support the development of education platforms and clinical care pathways to improve implementation of current guidelines, and develop research objectives for VTE prophylaxis in trauma. As an outcome of the conference, work has already begun to develop the next generation of VTE research studies.

To access the slide decks and videos of conference presentations, select them from the table below.

Presentation TitleSpeakerSlide DeckRecording
Overview of VTE/Coagulopathy in Trauma: Where have we been...Where are weWilliam Geerts, MD
University of Toronto
Geerts Slide DeckGeerts Recording
Current Evidence-based Guidelines for VTE ProphylaxisEric Ley, MD
University of California-Los Angeles
Ley Slide DeckLey Recording
VTE as a Hospital Quality Indicator Ajai Malhotra, MD
University of Vermont
Malhotra Slide DeckMalhotra Recording
VTE Prophylaxis: When can Anticoagulation Therapy be Safely Started after Injury?Truman Milling, Jr., MD
University of Texas at Austin
Milling Slide DeckMilling Recording
VTE Prophylaxis and DVT in Trauma: the good, the bad and the futureBellal Joseph, MD
University of Arizona
Joseph Slide DeckJoseph Recording
VTE Prophylaxis: Neurological Perspectives Thomas Beaumont, MD
University of California-San Diego
Beaumont Slide DeckBeaumont Recording
VTE Prophylaxis: Orthopedic Surgery PerspectivesAnna Miller, MD
Washington University
Miller Slide DeckMiller Recording
Consortium of Leaders in the Study of Traumatic Thromboembolism (CLOTT) UpdateM. Margaret Knudson, MD
University of California-San Francisco
Knudson Slide DeckKnudson Recording
Overcoming Barriers to Delivering VTE Prophylaxis in the Inpatient SettingElliott R. Haut, MD, PhD
Johns Hopkins University
Haut #1 Slide DeckHaut Recording #1
Use of Pharmacologic VTE Prophylaxis Post-discharge from Acute Care Hospitalization Alok Khorana, MD
Case Western Reserve University
Khorana Slide DeckKhorana Recording
Health Disparities in VTEMary Cushman, MD, MSc
Cushman Slide DeckCushman Recording
The Patient PerspectiveLeslie Lake
National Blood Clot Alliance
Lake Slide DeckLake Recording
The Future of Pharmacologic VTE Prophylaxis: Are Direct Oral Anticoagulants (DOACs) the Answer?Rachel Kruer, PharmD
Indiana University
Kruer Slide DeckKruer Recording
A Different Approach to Preventing Thrombosis (ADAPT)Deborah Stein, MD, MPH
Stein Slide DeckStein Recording
Does Aspirin have a Role in VTE Prevention in Trauma?John Fanikos, RPh, MBA
Brigham & Women's Hospital
Fanikos Slide DeckFanikos Recording
Current Research Gaps: Review of National Trauma Research Agenda (NTRAP) Delphi Survey ResultsTodd Costantini, MD
University of California-San Diego
Costantini Slide DeckCostantini Recording
Utilizing the TQIP Infrastructure to Measure Outcomes and ImplementationAvery Nathens, MD
Sunnybrook - Toronto
ACS-COT Trauma Quality Programs
Nathens Slide DeckNathens Recording
Implementation Science Approaches and Outcomes MeasurementElliott R. Haut, MD, PhD
Johns Hopkins University
Haut #2 Slide DeckHaut Recording #2

Funding for this conference was made possible (in part) by 1R13HL 158206 from the National Heart, Lung and Blood Institute, awarded to CNTR. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the NIH; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


Silver Level